Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles.
-
Christian B, Fabian E, Macha I, Mpangala S, Thio CL, Ulenga N, Mugusi F, Ammerman LR, Fawzi W, Green R, Murphy R, Hawkins C. Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy. AIDS. 2019 03 01; 33(3):465-473.
-
Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana. AIDS Res Hum Retroviruses. 2018 08; 34(8):667-671.
-
Yang E, Mphele S, Moshashane N, Bula B, Chapman J, Okatch H, Pettitt E, Tshume O, Marukutira T, Anabwani G, Lowenthal E. Distinctive barriers to antiretroviral therapy adherence among non-adherent adolescents living with HIV in Botswana. AIDS Care. 2018 Feb; 30(2):224-231.
-
Post FA, Tebas P, Clarke A, Cotte L, Short WR, Abram ME, Jiang S, Cheng A, Das M, Fordyce MW. Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):180-184.
-
Tedaldi EM, van den Berg-Wolf M, Richardson J, Patel P, Durham M, Hammer J, Henry K, Metzler S, Önen N, Conley L, Wood K, Brooks JT, Buchacz K. Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States. AIDS Patient Care STDS. 2012 Dec; 26(12):718-29.
-
Gaur AH, Flynn PM, Bitar W, Liang H. Optimizing frequency of CD4 assays in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2013 Mar; 29(3):418-22.
-
Morse CG, Voss JG, Rakocevic G, McLaughlin M, Vinton CL, Huber C, Hu X, Yang J, Huang da W, Logun C, Danner RL, Rangel ZG, Munson PJ, Orenstein JM, Rushing EJ, Lempicki RA, Dalakas MC, Kovacs JA. HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue. J Infect Dis. 2012 Jun 15; 205(12):1778-87.
-
Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Mulligan K. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin Infect Dis. 2012 Apr; 54(7):1013-25.
-
Cragin L, Pan F, Peng S, Zenilman JM, Green J, Doucet C, Chalfin DB, de Lissovoy G. Cost-effectiveness of a fourth-generation combination immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen for the detection of HIV infections in the United States. HIV Clin Trials. 2012 Jan-Feb; 13(1):11-22.
-
Tyagi M, Romerio F. Models of HIV-1 persistence in the CD4+ T cell compartment: past, present and future. Curr HIV Res. 2011 Dec 01; 9(8):579-87.